SightfileU.S. market data from official filings
Companies › PLSM
PULSENMORE LTD (PLSM)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0002064764 · EDGAR filings · Updated 2026-07-13
PULSENMORE LTD (PLSM) has reported institutional ownership of 5.2%, with 2 institutional managers holding positions valued at $1.18M per the latest 13F reporting period.
Institutional ownership
5.2%
Institutional managers
2
Reported 13F value
$1.18M
Latest updates
- 2026-07-13 — Prospectus supplement (424B3) filed
- 2026-07-13 — Foreign issuer report (6-K) filed
- 2026-07-10 — EFFECT filed
- 2026-07-07 — D filed
- 2026-07-02 — F-1 filed
- 2026-07-01 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PULSENMORE LTD has 2 institutional holders and institutional ownership of 5.2%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 3 reporting insiders, with a net reported value of $0.
Related companies
MILESTONE SCIENTIFIC INC (MLSS) · ANBIO BIOTECHNOLOGY (NNNN) · BiomX Inc (PHGE) · Lexaria Bioscience Corp (LEXX) · IGC PHARMA INC (IGC) · Alterity Therapeutics Ltd (ATHE)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.